Intercept Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Intercept Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Intercept Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Intercept Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Intercept Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Intercept Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Vivek Devaraj
Chairman; President - U.S. Executive BoardMr. Vivek Devaraj has been the Chairman and President of US division of the company since 2024. Prior to this, he served as the Director of the International Business Unit at Alfasigma Group. Previously, he served in Sandoz, Innovative Medicines and CIBA Vision business divisions at the Novartis group.
Rocco Venezia
Chief Financial Officer Senior ManagementMr. Rocco Venezia has been the Chief Financial Officer of the company since 2023. Prior to this, he served as the Chief Accounting Officer and Corporate Controller of the company. Previously, he served as the Assistant Corporate Controller at IKARIA Inc, which is part of Mallinckrodt Pharmaceuticals, from 2013 to 2016.
Jose Truzman
General Counsel - U.S. Senior ManagementVictoria Carey
Head - U.S. Strategic Marketing; Senior Vice President Senior ManagementDeryk David
Head - U.S. Sales; Senior Vice President Senior ManagementHave you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer